{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T05:30:43Z","timestamp":1793424643506,"version":"4.5.0"},"reference-count":131,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Urology"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1016\/j.eururo.2016.06.020","type":"journal-article","created":{"date-parts":[[2016,7,2]],"date-time":"2016-07-02T15:09:16Z","timestamp":1467472156000},"page":"462-475","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1221,"title":["Updated 2016 EAU Guidelines on Muscle-invasive and Metastatic Bladder Cancer"],"prefix":"10.1016","volume":"71","author":[{"given":"J.","family":"Alfred Witjes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thierry","family":"Lebret","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva M.","family":"Comp\u00e9rat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nigel C.","family":"Cowan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"De Santis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harman Maxim","family":"Bruins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginia","family":"Hern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Estefania Linares","family":"Espin\u00f3s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Dunn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathieu","family":"Rouanne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yann","family":"Neuzillet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik","family":"Veskim\u00e4e","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoine G.","family":"van der Heijden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgios","family":"Gakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria J.","family":"Ribal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.eururo.2016.06.020_bib0660","unstructured":"Phillips B, Ball C, Sackett D, et al. Oxford Centre for Evidence-based Medicine - levels of evidence. Oxford Centre for Evidence-based Medicine Web site. http:\/\/www.cebm.net\/oxford-centre-evidence-based-medicine-levels-evidence-march-2009\/. Updated March 2009."},{"key":"10.1016\/j.eururo.2016.06.020_bib0665","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1016\/j.ejca.2012.12.027","article-title":"Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012","volume":"49","author":"Ferlay","year":"2013","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.eururo.2016.06.020_bib0670","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.eururo.2012.07.033","article-title":"Epidemiology and risk factors of urothelial bladder cancer","volume":"63","author":"Burger","year":"2013","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2016.06.020_bib0675","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.eururo.2013.10.001","article-title":"International variations in bladder cancer incidence and mortality","volume":"66","author":"Chavan","year":"2014","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2016.06.020_bib0680","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1001\/jama.2011.1142","article-title":"Association between smoking and risk of bladder cancer among men and women","volume":"306","author":"Freedman","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/j.eururo.2016.06.020_bib0685","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1002\/(SICI)1097-0215(20000415)86:2<289::AID-IJC21>3.0.CO;2-M","article-title":"Cigarette smoking and bladder cancer in men: a pooled analysis of 11 case-control studies","volume":"86","author":"Brennan","year":"2000","journal-title":"Int J Cancer"},{"key":"10.1016\/j.eururo.2016.06.020_bib0690","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/j.ijrobp.2011.08.034","article-title":"Incidence of secondary cancer development after high-dose intensity-modulated radiotherapy and image-guided brachytherapy for the treatment of localized prostate cancer","volume":"83","author":"Zelefsky","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.eururo.2016.06.020_bib0695","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1007\/s11255-015-0980-6","article-title":"The impact of female gender on bladder cancer-specific death risk after radical cystectomy: a meta-analysis of 27,912 patients","volume":"47","author":"Liu","year":"2015","journal-title":"Int Urol Nephrol"},{"key":"10.1016\/j.eururo.2016.06.020_bib0700","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1093\/hmg\/ddt519","article-title":"Genome-wide association study identifies multiple loci associated with bladder cancer risk","volume":"23","author":"Figueroa","year":"2014","journal-title":"Human Mol Genet"},{"key":"10.1016\/j.eururo.2016.06.020_bib0705","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.eururo.2012.10.008","article-title":"A contemporary update on pathology standards for bladder cancer: transurethral resection and radical cystectomy specimens","volume":"63","author":"Hansel","year":"2013","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2016.06.020_bib0710","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.ccr.2014.01.009","article-title":"Identification of distinct basal and luminal subtypes of muscle-invasive bladder cancer with different sensitivities to frontline chemotherapy","volume":"25","author":"Choi","year":"2014","journal-title":"Cancer Cell"},{"key":"10.1016\/j.eururo.2016.06.020_bib0715","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1097\/01.ju.0000043639.55877.17","article-title":"Prognostic significance of vascular and perineural invasion in urothelial bladder cancer treated with radical cystectomy","volume":"169","author":"Leissner","year":"2003","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2016.06.020_bib0720","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1016\/j.eururo.2013.03.059","article-title":"Photodynamic diagnosis of non-muscle-invasive bladder cancer with hexaminolevulinate cystoscopy: a meta-analysis of detection and recurrence based on raw data","volume":"64","author":"Burger","year":"2013","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2016.06.020_bib0725","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1016\/j.crad.2011.05.019","article-title":"Bladder cancer: evaluation of staging accuracy using dynamic MRI","volume":"66","author":"Rajesh","year":"2011","journal-title":"Clin Radiol"},{"key":"10.1016\/j.eururo.2016.06.020_bib0730","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1016\/j.ejrad.2011.07.018","article-title":"Clinical value of FDG PET or PET\/CT in urinary bladder cancer: a systemic review and meta-analysis","volume":"81","author":"Lu","year":"2012","journal-title":"Eur J Radiol"},{"key":"10.1016\/j.eururo.2016.06.020_bib0735","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1111\/j.1464-410X.2007.06766.x","article-title":"Multidetector computed tomography urography for diagnosing upper urinary tract urothelial tumour","volume":"99","author":"Cowan","year":"2007","journal-title":"BJU Int"},{"key":"10.1016\/j.eururo.2016.06.020_bib0740","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1007\/s12149-012-0614-3","article-title":"Is whole-body fluorine-18 fluorodeoxyglucose PET\/CT plus additional pelvic images (oral hydration-voiding-refilling) useful for detecting recurrent bladder cancer?","volume":"26","author":"Yang","year":"2012","journal-title":"Ann Nucl Med"},{"key":"10.1016\/j.eururo.2016.06.020_bib0745","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/j.eururo.2011.12.009","article-title":"Diagnostic efficacy of [11C]choline positron emission tomography\/computed tomography compared with conventional computed tomography in lymph node staging of patients with bladder cancer prior to radical cystectomy","volume":"61","author":"Maurer","year":"2012","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2016.06.020_bib0750","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/j.eururo.2010.02.024","article-title":"Prevention and management of complications following radical cystectomy for bladder cancer","volume":"57","author":"Lawrentschuk","year":"2010","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2016.06.020_bib0755","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1097\/00005650-199611000-00004","article-title":"Comorbid illness is associated with survival and length of hospital stay in patients with chronic disability. A prospective comparison of three comorbidity indices","volume":"34","author":"Rochon","year":"1996","journal-title":"Med Care"},{"key":"10.1016\/j.eururo.2016.06.020_bib0760","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1111\/bju.12240","article-title":"The association of preoperative serum albumin level and American Society of Anesthesiologists (ASA) score on early complications and survival of patients undergoing radical cystectomy for urothelial bladder cancer","volume":"113","author":"Djaladat","year":"2014","journal-title":"BJU Int"},{"key":"10.1016\/j.eururo.2016.06.020_bib0765","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1111\/bju.12405","article-title":"Preoperative serum albumin is associated with mortality and complications after radical cystectomy","volume":"113","author":"Garg","year":"2014","journal-title":"BJU Int"},{"key":"10.1016\/j.eururo.2016.06.020_bib0770","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1002\/cncr.25345","article-title":"A population-based competing-risks analysis of the survival of patients treated with radical cystectomy for bladder cancer","volume":"117","author":"Lughezzani","year":"2011","journal-title":"Cancer"},{"key":"10.1016\/j.eururo.2016.06.020_bib0775","doi-asserted-by":"crossref","first-page":"E222","DOI":"10.1111\/j.1464-410X.2012.10938.x","article-title":"Predictive capacity of four comorbidity indices estimating perioperative mortality after radical cystectomy for urothelial carcinoma of the bladder","volume":"110","author":"Mayr","year":"2012","journal-title":"BJU Int"},{"key":"10.1016\/j.eururo.2016.06.020_bib0780","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.juro.2011.04.089","article-title":"Predicting the probability of 90-day survival of elderly patients with bladder cancer treated with radical cystectomy","volume":"186","author":"Morgan","year":"2011","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2016.06.020_bib0785","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1245\/s10434-011-1852-7","article-title":"Development and validation of a reference table for prediction of postoperative mortality rate in patients treated with radical cystectomy: a population-based study","volume":"19","author":"Abdollah","year":"2012","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.eururo.2016.06.020_bib0790","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/j.eururo.2012.03.057","article-title":"Comorbidity and performance indices as predictors of cancer-independent mortality but not of cancer-specific mortality after radical cystectomy for urothelial carcinoma of the bladder","volume":"62","author":"Mayr","year":"2012","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2016.06.020_bib0795","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1111\/j.1464-410X.2010.09417.x","article-title":"Management of elderly patients with urothelial carcinoma of the bladder: guideline concordance and predictors of overall survival","volume":"106","author":"Bolenz","year":"2010","journal-title":"BJU Int"},{"key":"10.1016\/j.eururo.2016.06.020_bib0800","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.eururo.2015.06.045","article-title":"EORTC nomograms and risk groups for predicting recurrence, progression, and disease-specific and overall survival in non-muscle-invasive stage Ta-T1 urothelial bladder cancer patients treated with 1\u20133 years of maintenance bacillus Calmette-Gu\u00e9rin","volume":"69","author":"Cambier","year":"2016","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2016.06.020_bib0805","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/j.eururo.2009.12.024","volume":"57","author":"Sylvester","year":"2010","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2016.06.020_bib0810","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.eururo.2009.04.038","article-title":"An individual patient data meta-analysis of the long-term outcome of randomised studies comparing intravesical mitomycin C versus bacillus Calmette-Gu\u00e9rin for non\u2013muscle-invasive bladder cancer","volume":"56","author":"Malmstrom","year":"2009","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2016.06.020_bib0815","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/j.eururo.2009.07.005","article-title":"Clinical outcome in a contemporary series of restaged patients with clinical T1 bladder cancer","volume":"56","author":"Dalbagni","year":"2009","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2016.06.020_bib0820","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.eururo.2011.05.045","article-title":"Long-term cancer-specific survival in patients with high-risk, non\u2013muscle-invasive bladder cancer and tumour progression: a systematic review","volume":"60","author":"van den Bosch","year":"2011","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2016.06.020_bib0825","series-title":"Guidelines on Non\u2013muscle-invasive Bladder Cancer (Ta, T1 and CIS). Edn. presented at: European Association of Urology annual meeting; March 12\u201314","author":"Babjuk","year":"2016"},{"key":"10.1016\/j.eururo.2016.06.020_bib0830","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1016\/j.eururo.2012.08.055","article-title":"Treatment options available for bacillus Calmette-Gu\u00e9rin failure in non\u2013muscle-invasive bladder cancer","volume":"62","author":"Yates","year":"2012","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2016.06.020_bib0835","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.eururo.2003.09.019","article-title":"Neoadjuvant cisplatinum based combination chemotherapy in patients with invasive bladder cancer: a combined analysis of two Nordic studies","volume":"45","author":"Sherif","year":"2004","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2016.06.020_bib0840","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1016\/j.ejca.2011.11.018","article-title":"Optimisation of the size variation threshold for imaging evaluation of response in patients with platinum-refractory advanced transitional cell carcinoma of the urothelium treated with vinflunine","volume":"48","author":"Krajewski","year":"2012","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.eururo.2016.06.020_bib0845","doi-asserted-by":"crossref","first-page":"e21","DOI":"10.1016\/j.ijrobp.2011.11.065","article-title":"Role of diffusion-weighted magnetic resonance imaging in predicting sensitivity to chemoradiotherapy in muscle-invasive bladder cancer","volume":"83","author":"Yoshida","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.eururo.2016.06.020_bib0850","doi-asserted-by":"crossref","unstructured":"Advanced Bladder Cancer (ABC) Meta-analysis Collaboration. Neoadjuvant chemotherapy in invasive bladder cancer: update of a systematic review and meta-analysis of individual patient data advanced bladder cancer (ABC) meta-analysis collaboration. Eur Urol 2005;48:202\u20135; discussion 205\u20136.","DOI":"10.1016\/j.eururo.2005.04.006"},{"key":"10.1016\/j.eururo.2016.06.020_bib0855","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1200\/JCO.2010.32.3139","article-title":"International phase III trial assessing neoadjuvant cisplatin, methotrexate, and vinblastine chemotherapy for muscle-invasive bladder cancer: long-term results of the BA06 30894 trial","volume":"29","author":"Griffiths","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.eururo.2016.06.020_bib0860","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1016\/j.juro.2012.10.120","article-title":"Pooled analysis of clinical outcomes with neoadjuvant cisplatin and gemcitabine chemotherapy for muscle invasive bladder cancer","volume":"189","author":"Yuh","year":"2013","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2016.06.020_bib0865","doi-asserted-by":"crossref","first-page":"317190","DOI":"10.1155\/2013\/317190","article-title":"Pathologic response rates of gemcitabine\/cisplatin versus methotrexate\/vinblastine\/Adriamycin\/cisplatin neoadjuvant chemotherapy for muscle invasive urothelial bladder cancer","volume":"2013","author":"Lee","year":"2013","journal-title":"Adv Urol"},{"key":"10.1016\/j.eururo.2016.06.020_bib0870","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1080\/00365590902854313","article-title":"Downstaging and survival benefits of neoadjuvant radiotherapy before cystectomy for patients with invasive bladder carcinoma","volume":"43","author":"Granfors","year":"2009","journal-title":"Scand J Urol Nephrol"},{"key":"10.1016\/j.eururo.2016.06.020_bib0875","first-page":"1931","article-title":"Planned preoperative radiation therapy in muscle invasive bladder cancer; results of a meta-analysis","volume":"18","author":"Huncharek","year":"1998","journal-title":"Anticancer Res"},{"key":"10.1016\/j.eururo.2016.06.020_bib0880","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1111\/j.1464-410X.2007.07132.x","article-title":"A delay in radical cystectomy of >3 months is not associated with a worse clinical outcome","volume":"100","author":"Nielsen","year":"2007","journal-title":"BJU Int"},{"key":"10.1016\/j.eururo.2016.06.020_bib0885","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1002\/cncr.24052","article-title":"Mortality increases when radical cystectomy is delayed more than 12 weeks: results from a Surveillance, Epidemiology, and End Results-Medicare analysis","volume":"115","author":"Gore","year":"2009","journal-title":"Cancer"},{"key":"10.1016\/j.eururo.2016.06.020_bib0890","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1111\/j.1464-410X.2008.08084_1.x","article-title":"A delay in radical cystectomy of >3 months is not associated with a worse clinical outcome","volume":"102","author":"Ayres","year":"2008","journal-title":"BJU Int"},{"key":"10.1016\/j.eururo.2016.06.020_bib0895","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.urology.2012.10.025","article-title":"Anatomic basis for lymph node counts as measure of lymph node dissection extent: a cadaveric study","volume":"81","author":"Davies","year":"2013","journal-title":"Urology"},{"key":"10.1016\/j.eururo.2016.06.020_bib0900","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1016\/j.eururo.2011.07.012","article-title":"Lymph node dissection technique is more important than lymph node count in identifying nodal metastases in radical cystectomy patients: a comparative mapping study","volume":"60","author":"Dorin","year":"2011","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2016.06.020_bib0905","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1111\/j.1464-410X.2009.08403.x","article-title":"Cancer-specific survival after radical cystectomy and standardized extended lymphadenectomy for node-positive bladder cancer: prediction by lymph node positivity and density","volume":"104","author":"Wiesner","year":"2009","journal-title":"BJU Int"},{"key":"10.1016\/j.eururo.2016.06.020_bib0910","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1016\/j.eururo.2014.05.031","article-title":"The impact of the extent of lymphadenectomy on oncologic outcomes in patients undergoing radical cystectomy for bladder cancer: a systematic review","volume":"66","author":"Bruins","year":"2014","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2016.06.020_bib0915","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1016\/j.urolonc.2014.01.017","article-title":"Extent of lymph node dissection and recurrence-free survival after radical cystectomy: a meta-analysis","volume":"32","author":"Mandel","year":"2014","journal-title":"Urol Oncol"},{"key":"10.1016\/j.eururo.2016.06.020_bib0920","doi-asserted-by":"crossref","first-page":"E39","DOI":"10.1111\/bju.12371","article-title":"Extended vs non-extended pelvic lymph node dissection and their influence on recurrence-free survival in patients undergoing radical cystectomy for bladder cancer: a systematic review and meta-analysis of comparative studies","volume":"113","author":"Bi","year":"2014","journal-title":"BJU Int"},{"key":"10.1016\/j.eururo.2016.06.020_bib0925","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/j.urology.2005.10.015","article-title":"Neurovascular preservation in orthotopic cystectomy: impact on female sexual function","volume":"67","author":"Bhatt","year":"2006","journal-title":"Urology"},{"key":"10.1016\/j.eururo.2016.06.020_bib0930","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.ejso.2013.02.004","article-title":"Preservation of the internal genital organs during radical cystectomy in selected women with bladder cancer: a report on 15 cases with long term follow-up","volume":"39","author":"Ali-El-Dein","year":"2013","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.eururo.2016.06.020_bib0935","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.eururo.2014.12.007","article-title":"Systematic review and cumulative analysis of perioperative outcomes and complications after robot-assisted radical cystectomy","volume":"67","author":"Novara","year":"2015","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2016.06.020_bib0940","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1016\/j.eururo.2014.11.043","article-title":"Comparing open radical cystectomy and robot-assisted laparoscopic radical cystectomy: a randomized clinical trial","volume":"67","author":"Bochner","year":"2015","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2016.06.020_bib0945","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1200\/JCO.2001.19.3.666","article-title":"Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients","volume":"19","author":"Stein","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.eururo.2016.06.020_bib0950","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.eururo.2014.12.009","article-title":"Best practices in robot-assisted radical cystectomy and urinary reconstruction: recommendations of the Pasadena Consensus Panel","volume":"67","author":"Wilson","year":"2015","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2016.06.020_bib0955","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.eururo.2014.12.008","article-title":"Systematic review and cumulative analysis of oncologic and functional outcomes after robot-assisted radical cystectomy","volume":"67","author":"Yuh","year":"2015","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2016.06.020_bib0960","doi-asserted-by":"crossref","first-page":"e95667","DOI":"10.1371\/journal.pone.0095667","article-title":"Laparoscopic versus open radical cystectomy in bladder cancer: a systematic review and meta-analysis of comparative studies","volume":"9","author":"Tang","year":"2014","journal-title":"PloS One"},{"key":"10.1016\/j.eururo.2016.06.020_bib0965","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1097\/01.ju.0000149679.56884.0f","article-title":"Urethral tumor recurrence following cystectomy and urinary diversion: clinical and pathological characteristics in 768 male patients","volume":"173","author":"Stein","year":"2005","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2016.06.020_bib0970","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1016\/j.eururo.2012.02.028","article-title":"Radical cystectomy for urothelial carcinoma of the bladder without neoadjuvant or adjuvant therapy: long-term results in 1100 patients","volume":"61","author":"Hautmann","year":"2012","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2016.06.020_bib0975","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1007\/s00345-012-0837-x","article-title":"The ileal neobladder in female patients with bladder cancer: long-term clinical, functional, and oncological outcome","volume":"30","author":"Jentzmik","year":"2012","journal-title":"World J Urol"},{"key":"10.1016\/j.eururo.2016.06.020_bib0980","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1016\/j.juro.2012.11.078","article-title":"Urinary functional outcome following radical cystoprostatectomy and ileal neobladder reconstruction in male patients","volume":"189","author":"Ahmadi","year":"2013","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2016.06.020_bib0985","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1111\/j.1464-410X.2010.10000.x","article-title":"The Z-shaped ileal neobladder after radical cystectomy: an 18 years experience with 329 patients","volume":"108","author":"Neuzillet","year":"2011","journal-title":"BJU Int"},{"key":"10.1016\/j.eururo.2016.06.020_bib0990","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.jamcollsurg.2009.09.026","article-title":"Fast track program in patients undergoing radical cystectomy: results in 362 consecutive patients","volume":"210","author":"Pruthi","year":"2010","journal-title":"J Am Coll Surg"},{"key":"10.1016\/j.eururo.2016.06.020_bib0995","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.juro.2013.08.019","article-title":"A new concept for early recovery after surgery for patients undergoing radical cystectomy for bladder cancer: results of a prospective randomized study","volume":"191","author":"Karl","year":"2014","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2016.06.020_bib1000","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.eururo.2014.02.036","article-title":"Alvimopan accelerates gastrointestinal recovery after radical cystectomy: a multicenter randomized placebo-controlled trial","volume":"66","author":"Lee","year":"2014","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2016.06.020_bib1005","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/j.eururo.2007.09.008","article-title":"Urinary diversions after cystectomy: the association of clinical factors, complications and functional results of four different diversions","volume":"53","author":"Nieuwenhuijzen","year":"2008","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2016.06.020_bib1010","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1097\/01.ju.0000051462.45388.14","article-title":"Long-term outcome of ileal conduit diversion","volume":"169","author":"Madersbacher","year":"2003","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2016.06.020_bib1015","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1097\/01.ju.0000131651.77048.73","article-title":"The orthotopic T pouch ileal neobladder: experience with 209 patients","volume":"172","author":"Stein","year":"2004","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2016.06.020_bib1020","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1016\/S0022-5347(05)66322-7","article-title":"Functional results of orthotopic ileal neobladder with serous-lined extramural ureteral reimplantation: experience with 450 patients","volume":"165","author":"Abol-Enein","year":"2001","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2016.06.020_bib1025","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1046\/j.1464-410X.2003.04274.x","article-title":"Results with radical cystectomy for treating bladder cancer: a \u2018reference standard\u2019 for high-grade, invasive bladder cancer","volume":"92","author":"Stein","year":"2003","journal-title":"BJU Int"},{"key":"10.1016\/j.eururo.2016.06.020_bib1030","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1097\/01.ju.0000149080.82697.65","article-title":"Health related quality of life after radical cystectomy and urinary diversion for bladder cancer: a systematic review and critical analysis of the literature","volume":"173","author":"Porter","year":"2005","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2016.06.020_bib1035","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1016\/j.urology.2014.05.046","article-title":"Prospective health-related quality of life analysis for patients undergoing radical cystectomy and urinary diversion","volume":"84","author":"Large","year":"2014","journal-title":"Urology"},{"key":"10.1016\/j.eururo.2016.06.020_bib1040","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1111\/bju.12440","article-title":"Prospective comparison of quality-of-life outcomes between ileal conduit urinary diversion and orthotopic neobladder reconstruction after radical cystectomy: a statistical model","volume":"113","author":"Singh","year":"2014","journal-title":"BJU Int"},{"key":"10.1016\/j.eururo.2016.06.020_bib1045","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s00345-013-1219-8","article-title":"Urinary functional outcomes in female neobladder patients","volume":"32","author":"Bartsch","year":"2014","journal-title":"World J Urol"},{"key":"10.1016\/j.eururo.2016.06.020_bib1050","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.urology.2005.03.031","article-title":"Urinary diversion in high-risk elderly patients: modified cutaneous ureterostomy or ileal conduit?","volume":"66","author":"Deliveliotis","year":"2005","journal-title":"Urology"},{"key":"10.1016\/j.eururo.2016.06.020_bib1055","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1159\/000094817","article-title":"Comparison of ileal conduit and transureteroureterostomy with ureterocutaneostomy urinary diversion","volume":"77","author":"Kilciler","year":"2006","journal-title":"Urol Int"},{"key":"10.1016\/j.eururo.2016.06.020_bib1060","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.eururo.2008.04.068","article-title":"Comparison of complications in three incontinent urinary diversions","volume":"54","author":"Pycha","year":"2008","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2016.06.020_bib1065","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1590\/S1677-55382010000500003","article-title":"Radical cystectomy with orthotopic neobladder for invasive bladder cancer: a critical analysis of long term oncological, functional and quality of life results","volume":"36","author":"Stenzl","year":"2010","journal-title":"Int Braz J Urol"},{"key":"10.1016\/j.eururo.2016.06.020_bib1070","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1007\/s00345-006-0061-7","article-title":"Radical cystectomy for invasive bladder cancer: long-term results of a standard procedure","volume":"24","author":"Stein","year":"2006","journal-title":"World J Urol"},{"key":"10.1016\/j.eururo.2016.06.020_bib1075","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1016\/j.juro.2010.05.037","article-title":"Lessons learned from 1,000 neobladders: the 90-day complication rate","volume":"184","author":"Hautmann","year":"2010","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2016.06.020_bib1080","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1111\/bju.12566","article-title":"Association of hospital volume with conditional 90-day mortality after cystectomy: an analysis of the National Cancer Data Base","volume":"114","author":"Nielsen","year":"2014","journal-title":"BJU Int"},{"key":"10.1016\/j.eururo.2016.06.020_bib1085","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s00345-010-0626-3","article-title":"Hospital volume and 90-day mortality risk after radical cystectomy: a population-based cohort study","volume":"29","author":"Porter","year":"2011","journal-title":"World J Urol"},{"key":"10.1016\/j.eururo.2016.06.020_bib1090","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.eururo.2012.08.050","article-title":"ICUD-EAU International Consultation on Bladder Cancer 2012: urinary diversion","volume":"63","author":"Hautmann","year":"2013","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2016.06.020_bib1095","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1016\/j.juro.2012.08.042","article-title":"Volume outcomes of cystectomy--is it the surgeon or the setting?","volume":"188","author":"Morgan","year":"2012","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2016.06.020_bib1100","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1056\/NEJMsa1010705","article-title":"Trends in hospital volume and operative mortality for high-risk surgery","volume":"364","author":"Finks","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.eururo.2016.06.020_bib1105","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1111\/bju.12638","article-title":"Variation in performance of candidate surgical quality measures for muscle-invasive bladder cancer by hospital type","volume":"115","author":"Corcoran","year":"2015","journal-title":"BJU Int"},{"key":"10.1016\/j.eururo.2016.06.020_bib1110","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1111\/bju.12288","article-title":"Benefit in regionalisation of care for patients treated with radical cystectomy: a nationwide inpatient sample analysis","volume":"113","author":"Ravi","year":"2014","journal-title":"BJU Int"},{"key":"10.1016\/j.eururo.2016.06.020_bib1115","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.eururo.2011.07.066","article-title":"External validation of postoperative nomograms for prediction of all-cause mortality, cancer-specific mortality, and recurrence in patients with urothelial carcinoma of the bladder","volume":"61","author":"Nuhn","year":"2012","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2016.06.020_bib1120","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.canep.2013.02.002","article-title":"Incidence, survival and mortality rates of stage-specific bladder cancer in United States: a trend analysis","volume":"37","author":"Abdollah","year":"2013","journal-title":"Cancer Epidemiol"},{"key":"10.1016\/j.eururo.2016.06.020_bib1125","first-page":"149","article-title":"Palliative treatment of intractable hematuria in context of advanced bladder cancer: a systematic review","volume":"6","author":"Ghahestani","year":"2009","journal-title":"Urol J"},{"key":"10.1016\/j.eururo.2016.06.020_bib1130","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.juro.2010.04.008","article-title":"Feasibility of radical transurethral resection as monotherapy for selected patients with muscle invasive bladder cancer","volume":"184","author":"Solsona","year":"2010","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2016.06.020_bib1135","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.3109\/0284186X.2014.928418","article-title":"A comparison of morbidity following conformal versus intensity-modulated radiotherapy for urinary bladder cancer","volume":"53","author":"Sondergaard","year":"2014","journal-title":"Acta Oncol"},{"key":"10.1016\/j.eururo.2016.06.020_bib1140","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.urolonc.2006.09.015","article-title":"Long-term outcome of radiation-based conservation therapy for invasive bladder cancer","volume":"25","author":"Chung","year":"2007","journal-title":"Urol Oncol"},{"key":"10.1016\/j.eururo.2016.06.020_bib1145","first-page":"CD002079","article-title":"Surgery versus radiotherapy for muscle invasive bladder cancer","author":"Shelley","year":"2002","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.eururo.2016.06.020_bib1150","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.clon.2014.05.007","article-title":"Curative therapy for bladder cancer in routine clinical practice: a population-based outcomes study","volume":"26","author":"Booth","year":"2014","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"10.1016\/j.eururo.2016.06.020_bib1155","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1002\/cncr.11232","article-title":"Can patient selection for bladder preservation be based on response to chemotherapy?","volume":"97","author":"Sternberg","year":"2003","journal-title":"Cancer"},{"key":"10.1016\/j.eururo.2016.06.020_bib1160","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1056\/NEJMoa1106106","article-title":"Radiotherapy with or without chemotherapy in muscle-invasive bladder cancer","volume":"366","author":"James","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.eururo.2016.06.020_bib1165","first-page":"985","article-title":"15-year survival rates after transurethral resection and radiochemotherapy or radiation in bladder cancer treatment","volume":"31","author":"Krause","year":"2011","journal-title":"Anticancer Res"},{"key":"10.1016\/j.eururo.2016.06.020_bib1170","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.eururo.2014.02.038","article-title":"Critical analysis of bladder sparing with trimodal therapy in muscle-invasive bladder cancer: a systematic review","volume":"66","author":"Ploussard","year":"2014","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2016.06.020_bib1175","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1634\/theoncologist.11-6-630","article-title":"The role of perioperative chemotherapy in the treatment of urothelial cancer","volume":"11","author":"Cohen","year":"2006","journal-title":"Oncologist"},{"key":"10.1016\/j.eururo.2016.06.020_bib1180","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.eururo.2013.08.033","article-title":"Adjuvant chemotherapy for invasive bladder cancer: a 2013 updated systematic review and meta-analysis of randomized trials","volume":"66","author":"Leow","year":"2014","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2016.06.020_bib1185","doi-asserted-by":"crossref","first-page":"4461","DOI":"10.1158\/1078-0432.CCR-10-0457","article-title":"The effectiveness of off-protocol adjuvant chemotherapy for patients with urothelial carcinoma of the urinary bladder","volume":"16","author":"Svatek","year":"2010","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.eururo.2016.06.020_bib1190","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/S1470-2045(14)71160-X","article-title":"Immediate versus deferred chemotherapy after radical cystectomy in patients with pT3-pT4 or N+ M0 urothelial carcinoma of the bladder (EORTC 30994): an intergroup, open-label, randomised phase 3 trial","volume":"16","author":"Sternberg","year":"2015","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.eururo.2016.06.020_bib1195","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S1470-2045(10)70275-8","article-title":"A consensus definition of patients with metastatic urothelial carcinoma who are unfit for cisplatin-based chemotherapy","volume":"12","author":"Galsky","year":"2011","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.eururo.2016.06.020_bib1200","first-page":"855","article-title":"A study of split-dose cisplatin-based neo-adjuvant chemotherapy in muscle-invasive bladder cancer","volume":"3","author":"Hussain","year":"2012","journal-title":"Oncol Lett"},{"key":"10.1016\/j.eururo.2016.06.020_bib1205","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1016\/j.ejca.2012.04.002","article-title":"Cisplatin and gemcitabine administered every two weeks in patients with locally advanced or metastatic urothelial carcinoma and impaired renal function","volume":"48","author":"Morales-Barrera","year":"2012","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.eururo.2016.06.020_bib1210","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1093\/annonc\/mds583","article-title":"Prospective, open-label, randomized, phase III study of two dose-dense regimens MVAC versus gemcitabine\/cisplatin in patients with inoperable, metastatic or relapsed urothelial cancer: a Hellenic Cooperative Oncology Group study (HE 16\/03)","volume":"24","author":"Bamias","year":"2013","journal-title":"Ann Oncol"},{"key":"10.1016\/j.eururo.2016.06.020_bib1215","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1200\/JCO.2011.37.3571","article-title":"Randomized phase II\/III trial assessing gemcitabine\/carboplatin and methotrexate\/carboplatin\/vinblastine in patients with advanced urothelial cancer who are unfit for cisplatin-based chemotherapy: EORTC study 30986","volume":"30","author":"De Santis","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.eururo.2016.06.020_bib1220","doi-asserted-by":"crossref","first-page":"5634","DOI":"10.1200\/JCO.2008.21.4924","article-title":"Randomized phase II\/III trial assessing gemcitabine\/carboplatin and methotrexate\/carboplatin\/vinblastine in patients with advanced urothelial cancer \u201cunfit\u201d for cisplatin-based chemotherapy: phase II--results of EORTC study 30986","volume":"27","author":"De Santis","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.eururo.2016.06.020_bib1225","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1093\/annonc\/mdr156","article-title":"Comparative effectiveness of cisplatin-based and carboplatin-based chemotherapy for treatment of advanced urothelial carcinoma","volume":"23","author":"Galsky","year":"2012","journal-title":"Ann Oncol"},{"key":"10.1016\/j.eururo.2016.06.020_bib1230","doi-asserted-by":"crossref","first-page":"4602","DOI":"10.1200\/JCO.2005.07.757","article-title":"Long-term survival results of a randomized trial comparing gemcitabine plus cisplatin, with methotrexate, vinblastine, doxorubicin, plus cisplatin in patients with bladder cancer","volume":"23","author":"von der Maase","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.eururo.2016.06.020_bib1235","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.ejca.2005.08.032","article-title":"Seven year update of an EORTC phase III trial of high-dose intensity M-VAC chemotherapy and G-CSF versus classic M-VAC in advanced urothelial tract tumours","volume":"42","author":"Sternberg","year":"2006","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.eururo.2016.06.020_bib1240","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1200\/JCO.2011.38.6979","article-title":"Randomized phase III study comparing paclitaxel\/cisplatin\/gemcitabine and gemcitabine\/cisplatin in patients with locally advanced or metastatic urothelial cancer without prior systemic therapy: EORTC Intergroup Study 30987","volume":"30","author":"Bellmunt","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.eururo.2016.06.020_bib1245","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1200\/JCO.2010.31.3304","article-title":"Randomized, double-blind study of denosumab versus zoledronic acid in the treatment of bone metastases in patients with advanced cancer (excluding breast and prostate cancer) or multiple myeloma","volume":"29","author":"Henry","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.eururo.2016.06.020_bib1250","doi-asserted-by":"crossref","first-page":"e25","DOI":"10.3747\/co.v18i1.695","article-title":"First- and second-line therapy for metastatic urothelial carcinoma of the bladder","volume":"18","author":"Yafi","year":"2011","journal-title":"Curr Oncol"},{"key":"10.1016\/j.eururo.2016.06.020_bib1255","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1093\/annonc\/mdq398","article-title":"Randomized phase III trial of 2nd line gemcitabine and paclitaxel chemotherapy in patients with advanced bladder cancer: short-term versus prolonged treatment [German Association of Urological Oncology (AUO) trial AB 20\/99]","volume":"22","author":"Albers","year":"2011","journal-title":"Ann Oncol"},{"key":"10.1016\/j.eururo.2016.06.020_bib1260","doi-asserted-by":"crossref","first-page":"4454","DOI":"10.1200\/JCO.2008.20.5534","article-title":"Phase III trial of vinflunine plus best supportive care compared with best supportive care alone after a platinum-containing regimen in patients with advanced transitional cell carcinoma of the urothelial tract","volume":"27","author":"Bellmunt","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.eururo.2016.06.020_bib1265","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1097\/01.ju.0000067601.29966.4a","article-title":"Is there a therapeutic role for post-chemotherapy retroperitoneal lymph node dissection in metastatic transitional cell carcinoma of the bladder?","volume":"169","author":"Sweeney","year":"2003","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2016.06.020_bib1270","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1097\/01.ju.0000099823.60465.e6","article-title":"Is there a role for surgery in the management of metastatic urothelial cancer? The M.D. Anderson experience","volume":"171","author":"Siefker-Radtke","year":"2004","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2016.06.020_bib1275","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.eururo.2010.05.041","article-title":"Do patients benefit from routine follow-up to detect recurrences after radical cystectomy and ileal orthotopic bladder substitution?","volume":"58","author":"Giannarini","year":"2010","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2016.06.020_bib1280","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.acuro.2013.01.005","article-title":"Follow-up after radical cystectomy based on patterns of tumour recurrence and its risk factors","volume":"37","author":"Huguet","year":"2013","journal-title":"Actas Urol Esp"},{"key":"10.1016\/j.eururo.2016.06.020_bib1285","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.eururo.2012.05.008","article-title":"Follow-up after surgical treatment of bladder cancer: a critical analysis of the literature","volume":"62","author":"Soukup","year":"2012","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2016.06.020_bib1290","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/j.eururo.2008.11.039","article-title":"Surgery for metastatic urothelial carcinoma with curative intent: the German experience (AUO AB 30\/05)","volume":"55","author":"Lehmann","year":"2009","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2016.06.020_bib1295","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1016\/j.juro.2012.08.017","article-title":"Upper urinary tract recurrence following radical cystectomy for bladder cancer: a meta-analysis on 13,185 patients","volume":"188","author":"Picozzi","year":"2012","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2016.06.020_bib1300","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.1016\/j.juro.2007.01.133","article-title":"Upper tract urothelial recurrence following radical cystectomy for transitional cell carcinoma of the bladder: an analysis of 1,069 patients with 10-year followup","volume":"177","author":"Sanderson","year":"2007","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2016.06.020_bib1305","doi-asserted-by":"crossref","first-page":"3291","DOI":"10.1200\/JCO.2013.54.3173","article-title":"Risk of fracture after radical cystectomy and urinary diversion for bladder cancer","volume":"32","author":"Gupta","year":"2014","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.eururo.2016.06.020_bib1310","series-title":"Guidelines on Urothelial Carcinomas of the Upper Urinary Tract. Edn. presented at: European Association of Urology annual meeting; March 12\u201314","author":"Roupr\u00eat","year":"2016"}],"container-title":["European Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0302283816302901?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0302283816302901?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T13:05:12Z","timestamp":1759583112000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0302283816302901"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3]]},"references-count":131,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,3]]}},"alternative-id":["S0302283816302901"],"URL":"https:\/\/doi.org\/10.1016\/j.eururo.2016.06.020","relation":{},"ISSN":["0302-2838"],"issn-type":[{"value":"0302-2838","type":"print"}],"subject":[],"published":{"date-parts":[[2017,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Updated 2016 EAU Guidelines on Muscle-invasive and Metastatic Bladder Cancer","name":"articletitle","label":"Article Title"},{"value":"European Urology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eururo.2016.06.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 European Association of Urology. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}